| Bioactivity | 3’-beta-Azido-2’,3’-dideoxy-5’-O-(4-methoxy-trityl)uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 3’-beta-Azido-2’,3’-dideoxy-5’-O-(4-methoxy-trityl)uridine |
| CAS | 2072145-36-7 |
| Formula | C29H27N5O5 |
| Molar Mass | 525.56 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
3’-beta-Azido-2’,3’-dideoxy-5’-O-(4-methoxy-trityl)uridine
CAS: 2072145-36-7 F: C29H27N5O5 W: 525.56
3’-beta-Azido-2’,3’-dideoxy-5’-O-(4-methoxy-trityl)uridine is a purine nucleoside analog. Purine nucleoside analogs
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.